BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17162534)

  • 1. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
    Hall AP
    Toxicol Pathol; 2006; 34(6):763-75. PubMed ID: 17162534
    [No Abstract]   [Full Text] [Related]  

  • 2. Pericytes and ocular diseases.
    Motiejūnaite R; Kazlauskas A
    Exp Eye Res; 2008 Feb; 86(2):171-7. PubMed ID: 18078933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy.
    Cai J; Kehoe O; Smith GM; Hykin P; Boulton ME
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2163-71. PubMed ID: 18436850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericytes and the pathogenesis of diabetic retinopathy.
    Hammes HP
    Horm Metab Res; 2005 Apr; 37 Suppl 1():39-43. PubMed ID: 15918109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
    Cai J; Ruan Q; Chen ZJ; Han S
    Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
    Raza A; Franklin MJ; Dudek AZ
    Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic interaction between retinal endothelial cells and pericytes from normal and diabetic rabbits, and phenotypic changes of diabetic cells.
    Morisaki N; Watanabe S; Fukuda K; Saito Y
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):67-77. PubMed ID: 10099841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal digest preparation: a method to study diabetic retinopathy.
    Dietrich N; Hammes HP
    Methods Mol Biol; 2012; 933():291-302. PubMed ID: 22893415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression.
    Feng Y; vom Hagen F; Pfister F; Djokic S; Hoffmann S; Back W; Wagner P; Lin J; Deutsch U; Hammes HP
    Thromb Haemost; 2007 Jan; 97(1):99-108. PubMed ID: 17200776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapy.
    Bagley RG; Rouleau C; Morgenbesser SD; Weber W; Cook BP; Shankara S; Madden SL; Teicher BA
    Microvasc Res; 2006 May; 71(3):163-74. PubMed ID: 16624341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents.
    Coucha M; Barrett AC; Bailey J; Abdelghani M; Abdelsaid M
    Vascul Pharmacol; 2020 Aug; 131():106761. PubMed ID: 32585189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting vessel abnormalization in cancer.
    Garber K
    J Natl Cancer Inst; 2007 Jul; 99(13):991-2, 995. PubMed ID: 17596567
    [No Abstract]   [Full Text] [Related]  

  • 13. Deletion of ocular transforming growth factor β signaling mimics essential characteristics of diabetic retinopathy.
    Braunger BM; Leimbeck SV; Schlecht A; Volz C; Jägle H; Tamm ER
    Am J Pathol; 2015 Jun; 185(6):1749-68. PubMed ID: 25857227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy.
    Ejaz S; Chekarova I; Ejaz A; Sohail A; Lim CW
    Diabetes Obes Metab; 2008 Jan; 10(1):53-63. PubMed ID: 17941874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
    Bikfalvi A
    J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of insulin-mediated vasoprotection: early effect of diabetes on pericyte-containing microvessels of the retina.
    Kobayashi T; Puro DG
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2350-5. PubMed ID: 17460301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of extracellular vesicle-induced vessel destabilization in diabetic retinopathy.
    Mazzeo A; Beltramo E; Iavello A; Carpanetto A; Porta M
    Acta Diabetol; 2015 Dec; 52(6):1113-9. PubMed ID: 26282100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel role of erythropoietin in proliferative diabetic retinopathy.
    Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.
    Virgintino D; Ozerdem U; Girolamo F; Roncali L; Stallcup WB; Perris R
    J Vasc Res; 2008; 45(2):129-31. PubMed ID: 17943023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.